BeStock  
Markets › Compare › LBRX vs TNDM

LBRX vs TNDM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LBRX · LB Pharmaceuticals$34.16 ▼ 0.29%
TNDM · Tandem Diabetes Care$15.84 ▼ 1.98%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73137201266330Oct 9, '25Apr 9, '26Oct 7, '26
  • LBRX +118.4%
  • TNDM +6.9%

Head to head

MetricLBRXTNDM
Price$34.16$15.84
Change today▼ 0.29%▼ 1.98%
Market cap$1.10B$1.10B
Return, 3 months+1.2%+3.1%
Return, year to date+53.5%-27.9%
Return, 1 year+127.1%+3.3%
P/E (TTM)-11.4-17.6
P/B3.38.5
P/E percentile vs own 5y84th30th
Dividend yield––
Revenue growth (YoY, latest qtr)–+5.8%
Net profit growth (YoY)-959.4%+59.6%
Gross margin–56.0%
Operating margin–-4.4%
Net margin–-6.1%
Return on equity-75.0%-48.0%
Analyst target vs. price+89.9%+77.9%
Analyst buy share100%58%
RSI (14)2636
30-day volatility44.4%52.9%
Max drawdown, 1 year-31.0%-54.6%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TNDM is the largest of the group by market value.
  • LBRX has returned the most over the past year.
  • TNDM carries the lowest trailing P/E.
  • LBRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top